STOCK TITAN

VCXBWS - VCXBWS STOCK NEWS

Welcome to our dedicated page for VCXBWS news (Ticker: VCXBWS), a resource for investors and traders seeking the latest updates and insights on VCXBWS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VCXBWS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VCXBWS's position in the market.

Rhea-AI Summary
10X Capital Venture Acquisition Corp. III (VCXB) received a notice from NYSE American regarding the late filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The company's independent registered public accounting firm needed more time to review its financial statements. 10X III has a six-month Cure Period to file the report and regain compliance with NYSE American's listing standards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
10X Capital Venture Acquisition Corp. III (VCXB) received a notice from NYSE Regulation for non-compliance with Section 1003(b)(i) of the NYSE American LLC Company Guide due to having fewer than 300 public shareholders. The company has until February 28, 2024, to submit a plan to regain compliance or face suspension and delisting procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
10X Capital Venture Acquisition Corp. III (VCXB) expects leadership changes with David Weisburd set to become the new CEO and Osman Ahmed as the new President, subject to board approval. Hans Thomas will remain as Chairman of the board of directors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) received a notice from NYSE American for not timely filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023. The company's independent registered public accounting firm required additional time to complete the review of financial statements. However, 10X III subsequently cured its non-compliance by filing the Quarterly Report on November 27, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U, VCXB, VCXB WS) is transferring the listing of its Class A Ordinary Shares, Warrants, and Units from NYSE to NYSE American. The transfer is motivated by more favorable thresholds for continued listing. Trading on NYSE will end on October 6, 2023, and trading on NYSE American will commence on October 9, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
American Gene Technologies International Inc. (AGT) and 10X Capital Venture Acquisition Corp. III (VCXB) announced a merger agreement to form Addimmune, a publicly listed company focused on developing a functional cure for HIV. The investigational cell therapy, AGT103-T, has shown positive safety results in Phase I trials and will be targeted towards the 38 million people living with HIV globally. The proposed transaction represents a pre-money enterprise value of $500 million for Addimmune, with an additional earnout of up to $300 million tied to clinical and priced-based milestones.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
Rhea-AI Summary

Sparks Energy, Inc. has announced a merger agreement with 10X Capital Venture Acquisition Corp. III (NYSE: VCXB). The transaction will create a publicly traded company under the ticker symbol 'SPKS'. Sparks specializes in power infrastructure recovery services, responding to outages caused by extreme weather across the U.S. With increasing demand due to climate change and investment in renewables, the merger positions Sparks for growth. The pro forma enterprise value of the combined entity is estimated at $475 million, aided by a $50 million equity facility, and is expected to close in 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U) announced that starting March 4, 2022, investors can separately trade its Class A ordinary shares and warrants from its initial public offering units. The Class A ordinary shares will trade under the symbol VCXB and warrants under VCXBWS, while units that are not separated will continue trading as VCXB.U. It’s important to note that only whole warrants will be traded, and holders must contact Continental Stock Transfer & Trust Company for the separation process. The offering's registration statement was effective January 11, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U) has successfully completed its initial public offering of 30,000,000 units, raising gross proceeds of $300 million. The offering was upsized and included the exercise of an over-allotment option for an additional 3,900,000 units. Each unit comprises one Class A ordinary share and one-half of a redeemable warrant, with full warrants exercisable at $11.50 per share. The units and individual securities will trade under the symbols VCXB and VCXB.WS. Funds from the IPO are primarily allocated into a trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

10X Capital Venture Acquisition Corp. III has announced the successful pricing of its initial public offering (IPO) of 26,100,000 units at $10.00 per unit. The units will trade on the NYSE under the ticker symbol VCXB.U starting January 12, 2022. Each unit consists of one Class A ordinary share and one-half of a redeemable warrant, with whole warrants exercisable to purchase one Class A share at $11.50.

As a blank-check company, its focus is on merging with high-growth technology businesses. Cantor Fitzgerald & Co. is managing the offering, with a 45-day option for underwriters to purchase additional units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
VCXBWS

NYSE:VCXBWS

VCXBWS Rankings

VCXBWS Stock Data